Intravenous Dexamethasone to Increase the Analgesic Duration of Interscalene Block

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

November 30, 2015

Conditions
Pain
Interventions
DRUG

Dexamethasone

After the performance of inter scalene plexus blockade, patients will either receive dexamethasone 10 mg i.v. (diluted with 17.5 mL normal saline), dexamethasone 4 mg i.v. (diluted with 19 mL normal saline), or normal saline 20 ml i.v.

DRUG

Normal Saline

Trial Locations (3)

J4M 2A5

Hopital Pierre-Boucher, Longueuil

H1T 4M5

Maisonneuve-Rosemont Hospital, Montreal

J3P 1N5

Hopital Hotel-Dieu de Sorel, Sorel-Tracy

All Listed Sponsors
lead

Maisonneuve-Rosemont Hospital

OTHER

NCT02412657 - Intravenous Dexamethasone to Increase the Analgesic Duration of Interscalene Block | Biotech Hunter | Biotech Hunter